These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1465851)

  • 21. IgM antibodies identified by a DTT-ameliorated positive crossmatch do not influence renal graft outcome but the strength of the IgM lymphocytotoxicity is associated with DR phenotype.
    Bryan CF; Martinez J; Muruve N; Nelson PW; Pierce GE; Ross G; Shield CF; Warady BA; Aeder MI; Harrell KM; Helling TS; Luger AM
    Clin Transplant; 2001; 15 Suppl 6():28-35. PubMed ID: 11903383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The prognostic significance of pre-existing lymphocytotoxic antibodies in cadaveric kidney allografts with a negative specific crossmatch].
    Kharlamova LA; Zemlianitskaia TL; Makhlin NV; Iankovoĭ
    Urol Nefrol (Mosk); 1993; (4):30-2. PubMed ID: 8310563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IgM antibodies in renal transplantation.
    McCalmon RT; Tardif GN; Sheehan MA; Fitting K; Kortz W; Kam I
    Clin Transplant; 1997 Dec; 11(6):558-64. PubMed ID: 9408684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
    Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
    Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of panel-reactive antibody in predicting crossmatch selection of cadaveric kidney recipients.
    Lieber SR; Perez FV; Tabossi MR; Persoli LB; Marques SB; Mazzali M; Alves-Filho G; de Souza CA
    Transplant Proc; 2007 Mar; 39(2):429-31. PubMed ID: 17362748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Donor specific CDC lymphocyte crossmatch and five year allograft survival.
    Sharma RK; Singh AK; Agrawal S; Gupta A; Avula S; Kumar A; Kapoor R; Bhandari M
    Transplant Proc; 1998 Nov; 30(7):2966. PubMed ID: 9838309
    [No Abstract]   [Full Text] [Related]  

  • 27. Incidence of a positive final antiglobulin (AHG) T-cell crossmatch in patients waiting for cadaveric renal transplantation is not influenced by race of recipient.
    Bryan CF; Aeder MI; Luger AM; Nelson PW; Pierce GE; Ross G; Shield CF; Warady BA
    Transplant Proc; 1993 Dec; 25(6):3273-4. PubMed ID: 8266539
    [No Abstract]   [Full Text] [Related]  

  • 28. Current experience with renal transplantation across the ABO blood group barrier.
    Bryan CF; Nelson PW; Aeder MI; Beck ML; Helling TS; Hughes TM; Luger AM; Pierce GE; Shield CF
    Transplant Proc; 1992 Dec; 24(6):2527-9. PubMed ID: 1465854
    [No Abstract]   [Full Text] [Related]  

  • 29. Weak humoral posttransplant alloresponse after a well-HLA-matched cadaveric kidney transplantation.
    Matinlauri IH; Kyllönen LE; Eklund BH; Koskimies SA; Salmela KT
    Transplantation; 2004 Jul; 78(2):198-204. PubMed ID: 15280678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Self-MHC restricted T cells specific for donor peptides infiltrate human grafts during rejection.
    Colovai AI; Liu Z; Cinti P; Harris PE; Drusin RE; Mancini DM; Gargano F; Hardy MA; Cortesini R; Rose EA; Suciu-Foca N
    Transplant Proc; 1997; 29(1-2):1509-10. PubMed ID: 9123402
    [No Abstract]   [Full Text] [Related]  

  • 31. Specific HLA antibody production following renal transplantation.
    Martin S; Dyer PA; Gokal R; Mallick NP; Johnson RW
    Transplant Proc; 1987 Feb; 19(1 Pt 1):898. PubMed ID: 3274885
    [No Abstract]   [Full Text] [Related]  

  • 32. Four short projects about antibodies, soluble CD30, and organ transplant rejection.
    Stastny P; Spells K; Rogers J; Zou Y; Lavingia B
    Clin Transpl; 2006; ():337-47. PubMed ID: 18365388
    [No Abstract]   [Full Text] [Related]  

  • 33. Biomarkers in transplantation: Prospective, blinded measurement of predictive value for the flow cytometry crossmatch after negative antiglobulin crossmatch in kidney transplantation.
    Wen R; Wu V; Dmitrienko S; Yu A; Balshaw R; Keown PA;
    Kidney Int; 2006 Oct; 70(8):1474-81. PubMed ID: 16941026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specificity of preformed alloantibodies causing B cell positive flow crossmatch in renal transplantation.
    Lobashevsky AL; Senkbeil RW; Shoaf J; Mink C; Rowe C; Lobashevsky ES; Burke R; Hudson S; Deierhoi MH; Thomas JM
    Clin Transplant; 2000 Dec; 14(6):533-42. PubMed ID: 11127305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction between panel reactive antibodies, auto- and cold reactive antibodies, and a positive B cell cross-match in renal and cardiac allograft survival.
    Creemers P; Brink J; Kahn D
    Clin Transplant; 1997 Apr; 11(2):134-8. PubMed ID: 9113450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Harmful effect of preformed anti-MICA antibodies on renal allograft evolution in early posttransplantation period.
    Sánchez-Zapardiel E; Castro-Panete MJ; Castillo-Rama M; Morales P; Lora-Pablos D; Valero-Hervás D; Ruiz-García R; Apaza J; Talayero P; Andrés A; Morales JM; Paz-Artal E
    Transplantation; 2013 Jul; 96(1):70-8. PubMed ID: 23624543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of protective genes in the HLA system on renal graft survival.
    Mikłaszewicz A; Giedrys-Kalemba S; Teodorczyk U; Hałasa J; Goertz K; Zieliński S; Ostrowski M; Kostyrka R; Lapis J; Kulig G; Kulig T; Kruszewski T; Kozłowski M; Lewiński D; Grzywacz B; Grzywacz M; Kuprjanowicz L
    Transplant Proc; 2000 Sep; 32(6):1337-8. PubMed ID: 10995972
    [No Abstract]   [Full Text] [Related]  

  • 38. Anti-class II antibodies in kidney transplant patients.
    Rebibou JM; Bittencourt MC; Ducloux D; Chabod J; Thévenin C; Chalopin JM; Hervé P; Tiberghien P
    Transplant Proc; 2000 Dec; 32(8):2748-9. PubMed ID: 11134785
    [No Abstract]   [Full Text] [Related]  

  • 39. Antibodies to vascular endothelial cells in chronic rejection of renal allografts.
    Ball B; Mousson C; Ratignier C; Guignier F; Glotz D; Rifle G
    Transplant Proc; 2000 Mar; 32(2):353-4. PubMed ID: 10715436
    [No Abstract]   [Full Text] [Related]  

  • 40. Major histocompatibility complex class I-related chain A allele mismatching, antibodies, and rejection in renal transplantation.
    Cox ST; Stephens HA; Fernando R; Karasu A; Harber M; Howie AJ; Powis S; Zou Y; Stastny P; Madrigal JA; Little AM
    Hum Immunol; 2011 Oct; 72(10):827-34. PubMed ID: 21664940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.